Relieve Pain and Improve Your Sex Life With Neogyn
Vulvar pain and discomfort threatens the wellness, sexual satisfaction, and emotional well-being of at least 14 million women at some point in their lives, but only one-third will seek treatment. The condition is particularly problematic for post-menopausal women. A new study spearheaded by the Southern California Center for Health & Survivorship Medicine and the Academic Urology Center for Pelvic Medicine concludes that the vulvar-soothing cream Neogyn meaningfully alleviates these symptoms in otherwise healthy post-menopausal women.
A 12-week evaluation of post-menopausal women who had substantial vulvar pain and sexual dysfunction prior to beginning treatment with Neogyn saw marked improvements in their comfort levels (61 percent) and the quality of their sex lives (57 percent), as well as overall meaningful benefits from Neogyn (78 percent).
Subjects selected for the study, 24 women between the ages of 53 and 80 from clinics in two different regions of the US, did not use any other treatments for vulvar pain during the study.
Initial 2013 assessments in June and subsequently in November consisted of an 11-point numeric rating scale of discomfort, the Female Sexual Function Index (FSFI), and the McGill Genital Pain Questionnaire. Global assessments of the treatment were also made at four and eight weeks.
Neogyn Vulvar Soothing Cream was specifically formulated and designed to relieve chronic mild-to-moderate discomfort or pain in the external genital area around the opening of the vagina. Swiss scientists formulated the proprietary blend of proteins to create a hormone- fragrance- and paraben- free soothing cream.
Michael Krychman, MD, one of the study’s authors and Executive Director of the California-based Center, concludes, “Our research made it clear that Neogyn can relieve vulvar pain and discomfort and improve sexual well-being in many post-menopausal women.” Krychman will present the findings at The North American Menopause Society (NAMS) 2014 Conference on October 15-18, 2014 in Washington, DC. Dr. Susan Kellogg Spadt, PhD, sexual health expert and Director of Female Sexual Medicine at the Academic Urology Center for Pelvic Medicine outside of Philadelphia, and another of the study’s authors, points out that any woman might develop vaginal pain and discomfort, but the following categories of women are especially vulnerable: menopausal and post-menopausal women, birth control users, cancer survivors, and women with certain chronic medical conditions.
Neogyn’s development was inspired by clinical research regarding wound healing conducted at the University Hospital of Lausanne, Switzerland, a leading international medical research facility.